Abstract
Globally, the incidence of lung cancer continues to rise drastically in parallel with increased tobacco consumption but with wide geographic variations. Despite the enforcement of more rigid health policies in many countries, lung cancer will for many years to come be a recurrent disease which most physicians will be confronted with at regular intervals. Furthermore, variations in the management of lung cancer occur from region to region influenced by differences in traditions, knowledge, healthcare systems and available resources. In this article a brief overview is presented of the management of both non-small cell and small cell lung cancer including recent results that may have an impact on the management of this disease.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
